Venlafaxine Extended-Release Tablets, 150mg, Rx only, 90 Tablets, Manufactured by Appco Pharma. LLC, NDC 43598-943-90.
Published January 29, 2025 · Recall initiated: January 16, 2025
Summary
FDA records drug Class III recall D-0208-2025, published January 29, 2025 and initiated January 16, 2025. Recalling firm: Appco Pharma LLC; Status: Completed; Reported quantity: 1380 bottles; Lot: Lot #: 2402101UR, Exp 02/28/2027. Class III means the product is not likely to cause adverse health consequences.
Status when published: Completed — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Tablet/Capsule Specifications: Missing tab ID on either side of the tablet
What to do
Voluntary: Firm initiated · Letter
Get an email if VENLAFAXINE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- VENLAFAXINE
- Manufacturer
- Appco Pharma LLC
- Distributor
- Nationwide USA.
- UPC
- 0343598943909
- Lot
- Lot #: 2402101UR, Exp 02/28/2027
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAVenlafaxine Tablets, USP, 75 mg, 100 Tablets, Rx only, Mfg. by: Zydus Lifesciences Ltd, Ahmedabad, India,April 16, 2025
- FDAFOUZEE SugarLin HERBAL FORMULA capsules, 180 capsules per bottle, Sold and Distributed by Shoppers-Plaza,January 29, 2025
- FDAMr. Bing brand Sriracha Chili Sauce; 9 oz and 18 oz, in clear PET bottle with green cap; UPC 850044819072 andJanuary 29, 2025
- FDAFirst Aid Beauty Ultra Repair Cream, colloidal oatmeal 0.5%, Coconut Vanilla, Net Wt. 396.8 g (14 OZ), DISTR.January 29, 2025
- FDAVenlafaxine 75 mg Tablet, Compare to Effexor 75 mg Tablet, a) 30-count bottle (NDC 636290-3324-2), b)May 11, 2016
- FDAVenlafaxine Hydrochloride Tablets, 75 mg*, 100-count tablets per bottle, Rx only, Manufactured by: CadilaApril 3, 2013
Questions about this recall
Was Venlafaxine Extended-Release Tablets, 150mg, Rx only, 90 Tablets, Manufactured by Appco Pharma. LLC, NDC 43598-943-90. recalled?
Yes. FDA published recall D-0208-2025 on January 29, 2025. Reported hazard: Failed Tablet/Capsule Specifications: Missing tab ID on either side of the tablet
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: VENLAFAXINE. UPC: 0343598943909.